Skip to main content

A Prospective Safety Sub-Registsry to Assess Anaphylaxis and Severe Allegric Reactions and Severe Cutaneious and Systemic Immune-mediated Reactions with Alglucosidase Alfa Treatment

Clinical Trial Grant
Duke Scholars

Administered By

Pediatrics, Medical Genetics

Awarded By

Genzyme Corporation

Start Date

October 10, 2016

End Date

September 30, 2021
 

Administered By

Pediatrics, Medical Genetics

Awarded By

Genzyme Corporation

Start Date

October 10, 2016

End Date

September 30, 2021